Search

everythinglearnresearchcommunity

for

Search:↓

DCP in isopropanol is better tolerated for treating alopecia areata.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

New methods efficiently isolate dermal papilla cells from hair follicles, preserving their characteristics better than traditional methods.

Arabidopsis PCaP2 helps plants survive drought by linking ABA and SA signals.

A child with skin and tooth symptoms was found to have a genetic mutation causing cardiocutaneous syndrome, leading to heart problems.

LPA 4 helps control blood and lymph vessel development in zebrafish.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

RADA-PDGF2 hydrogel speeds up wound healing and is safe for use.

Phospholipase C-δ1 is crucial for normal hair development.

The prototype for analyzing skin aging works technically and clinically.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

lncRNA2919 slows down rabbit hair growth by stopping cell growth and causing cell death.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Danon disease can be hard to diagnose due to non-specific symptoms.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Vitamin C derivative reduces hair loss-related protein in cells.

Dsg1 is essential for maintaining a healthy skin barrier in mice.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

AP-1 controls tumor cell type by affecting key signaling pathways.

A boy with Oculodentodigital syndrome had a unique GJA1 gene mutation causing his symptoms.